Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals granted inducement equity awards to 26 new non-executive employees under its 2025 Inducement Plan, approved by the independent Compensation Committee per Nasdaq Listing Rule 5635(c)(4). The aggregate grant was 9,642 time-based restricted stock units vesting in four equal annual installments, contingent on continued employment.
Key figures
- Vesting
- four equal annual installments from grant date
- Rsu granted
- 9642
- New employees
- 26
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.